Align Technology Inc

ALGNNASDAQ · USD
163.96USD0.00 (+0.31%)
879

Align Technology Inc (ALGN) Option Chain

Align Technology Inc trades at $163.96, up 0.31%, with an IV Rank of 21.83%. This is low versus the past year, and the company carries a market cap of $11,557M in the Medical Instruments & Supplies industry. On the Nov 20, 2026 chain, the at the money $165.00 strike shows calls at $0.15 / $4.70 and puts at $1.40 / $7.20, both carrying about $2.84 of extrinsic value. The call has a 59.63% probability of expiring out of the money, and the put has 40.37%. Volume is heaviest on the $177.50 calls, at 12 contracts, and the $152.50 puts, at 7, as of Nov 18, 2026.

Read more

Tracking the ALGN option chain helps you see every strike and expiry on Align Technology Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ALGN options activity at a glance. Use our scanner to monitor the ALGN option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ALGN stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ALGN options are being actively traded, and where they are not.

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
18.035902.293.964.707.80160.00-2.421.403.500.002.4503581.97
37.042702.811.461.557.00162.50-0.890.154.600.002.3804462.96
59.6310002.430.000.154.70165.00+0.631.407.201.043.2603940.37
79.09912.150.000.304.00167.50+2.162.857.703.541.740420.91
91.426301.800.00—1.80170.00+3.684.6011.306.041.910428.58

As of Nov 18, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryMedical Instruments & Supplies
  • SectorHealthcare
  • IV Rank21.83% Low
  • Market cap (M$)11,557
  • 52 weeks high-18.20%
  • 52 weeks low24.26%
  • Analyst recommendationBuy
    2.29
  • Target price$185.08
    12.88% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2027-02-03
  • P/E23.82
  • Future P/E13.36
  • EPS (ttm)6.88
  • EPS growth next 5 years8.46%

As of Nov 18, 2026